207 Spam-Free Article(s) Found
Sort:
Relevance
Filter:
All
Article Searches
Stifel upgrades Masimo to buy, sees room for share price appreciation https://seekingalpha.com/news/4089749-stifel-upgrades-masimo-to-buy-sees-room-for-share-price-appreciation?source=feed_sector_healthcare Apr 15, 2024 - Stifel upgraded Masimo (MASI) to buy, citing improvement in the company's healthcare business, gross margin expansion, cost reductions and the separation of its consumer business.
Wall Street Analysts See Crescent Point (CPG) as a Buy: Should You Invest? https://www.zacks.com/stock/news/2255218/wall-street-analysts-see-crescent-point-cpg-as-a-buy-should-you-invest?cid=CS-ZC-FT-fundamental_analysis|average_broker_rating-2255218 Apr 15, 2024 - According to the average brokerage recommendation (ABR), one should invest in Crescent Point (CPG). It is debatable whether this highly sought-after metric is effective because Wall Street analysts' recommendations tend to be overly optimistic. Would it be worth investing in the stock?
Wall Street pushes out rate-cut expectations, sees risk they don't start until March 2025 https://www.cnbc.com/2024/04/17/wall-street-pushes-out-rate-cut-expectations-sees-risk-of-no-action-until-2025.html Apr 17, 2024 - Experts now see the Fed waiting until at least September and are increasingly entertaining the possibility of no cuts at all this year.
Wall Street Analysts See SentinelOne (S) as a Buy: Should You Invest? https://www.zacks.com/stock/news/2258414/wall-street-analysts-see-sentinelone-s-as-a-buy-should-you-invest?cid=CS-ZC-FT-fundamental_analysis|average_broker_rating-2258414 Apr 19, 2024 - Based on the average brokerage recommendation (ABR), SentinelOne (S) should be added to one's portfolio. Wall Street analysts' overly optimistic recommendations cast doubt on the effectiveness of this highly sought-after metric. So, is the stock worth buying?
Wall Street Analysts See HubSpot (HUBS) as a Buy: Should You Invest? https://www.zacks.com/stock/news/2258422/wall-street-analysts-see-hubspot-hubs-as-a-buy-should-you-invest?cid=CS-ZC-FT-fundamental_analysis|average_broker_rating-2258422 Apr 19, 2024 - The average brokerage recommendation (ABR) for HubSpot (HUBS) is equivalent to a Buy. The overly optimistic recommendations of Wall Street analysts make the effectiveness of this highly sought-after metric questionable. So, is it worth buying the stock?
UBS sees earnings heading for strongest pace of quarterly growth in more than 2 years https://seekingalpha.com/news/4093721-ubs-sees-q1-earnings-heading-for-strongest-pace-of-growth-in-more-than-2-years?source=feed_sector_healthcare Apr 24, 2024 - UBS sees corporate earnings heading toward biggest quarterly growth rate since 2021. Read more here.
U.S. Stocks May See Further Upside On Upbeat Earnings News https://www.rttnews.com/story.aspx?Id=3441278 Apr 24, 2024 - After moving notably higher over the two previous sessions, stocks are likely to see further upside in early trading on Wednesday. The major index futures are currently pointing to a positive open for the markets, with the S&P 500 futures up by 0.3 percent.
Wall Street Analysts See a 29.46% Upside in AudioEye (AEYE): Can the Stock Really Move This High? https://www.zacks.com/stock/news/2264172/wall-street-analysts-see-a-29-46-upside-in-audioeye-aeye-can-the-stock-really-move-this-high?cid=CS-ZC-FT-tale_of_the_tape|consensus_price_target-2264172 Apr 29, 2024 - The consensus price target hints at a 29.5% upside potential for AudioEye (AEYE). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.
Sealed Air (SEE) to Report Q1 Earnings: What to Expect? https://www.zacks.com/stock/news/2264421/sealed-air-see-to-report-q1-earnings-what-to-expect?cid=CS-ZC-FT-analyst_blog|earnings_preview-2264421 Apr 29, 2024 - Sealed Air's (SEE) Q1 results are likely to reflect the impacts of lower volumes, owing to recessionary pressures in the industrial and fulfillment market, and food market declines.
R1 RCM may see $15 a share in LBO; deal looks more likely now https://seekingalpha.com/news/4096668-r1-rcm-may-see-15-a-share-in-lbo-deal-looks-more-likely-now?source=feed_sector_healthcare Apr 30, 2024 - R1 RCM's potential takeover by New Mountain and TowerBrook could value the company at $15 a share, as per a Jefferies analyst.

Pages: 1...345678910111213...21

<<<Page 8>